Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
02/2000
02/17/2000CA2337980A1 Method to alter the fatty acid metabolism in plants
02/17/2000CA2336064A1 Fibrous proteins and the production thereof
02/17/2000CA2305784A1 Mutated barnase gene and plant transformed by the same
02/17/2000CA2305680A1 Death associated kinase containing ankyrin repeats (dakar)
02/17/2000CA2305308A1 Human cdnas encoding polypeptides having kinase functions
02/16/2000EP0979874A2 Protein and DNA sequence for pinosylvine-3-O-methyltransferase (PMT)
02/16/2000EP0979816A1 Hydroxamic acid derivatives, process for their preparation and pharmaceutical compositions containing them
02/16/2000EP0979301A1 Pseudomonas alginovora strain producing alginate-lyase and its use for the depolymerisation of alginate
02/16/2000EP0979296A2 Plant amino acid biosynthetic enzymes
02/16/2000EP0979294A2 Gene conversion as a tool for the construction of recombinant industrial filamentous fungi
02/16/2000EP0979293A1 Transcriptional silencing elements and their binding factors
02/16/2000EP0979292A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
02/16/2000EP0979289A1 Human lysophospholipase
02/16/2000EP0979288A2 Diagnosis and treatment of phosphatase- or kinase-related disorders
02/16/2000EP0979287A2 Production of ascorbic acid in plants
02/16/2000EP0979277A1 Novel human tumour suppressor gene
02/16/2000EP0979271A1 Vascular adhesion protein-1 having amine oxidase activity
02/16/2000EP0979237A1 Method for removing viruses from protein solution by nanofiltration
02/16/2000EP0979093A1 Arrestable therapeutic viral agent
02/16/2000EP0979088A1 Method of inducing vasodilation and treating pulmonary hypertension using adenoviral-mediated transfer of the nitric oxide synthase gene
02/16/2000EP0979036A2 Enzyme concentrate
02/16/2000CN1244894A Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
02/16/2000CN1244871A H. pylori antigens
02/15/2000US6025542 Method for obtaining transgenic plants showing a modified fructan pattern
02/15/2000US6025541 Isolated non-coding nucleotide sequences useful as promoters for heterologous gene expression in plants
02/15/2000US6025540 Transgenic non-human mammal comprising a dna sequence encoding human extracellular superoxide dismutase (human ec-sod) or a variant thereof which is expressed in the milk
02/15/2000US6025500 Heterogeneous catalytic reductive amination between alanylproline and ethyl-2-oxo-4-phenylbutyrate
02/15/2000US6025342 Analog of Haemophilus Hin47 with reduced protease activity
02/15/2000US6025340 Surface expression of enzyme in gene directed prodrug therapy
02/15/2000US6025333 Treatment of CNS tumors with metalloprotease inhibitors
02/15/2000US6025330 Inhibitors of fibrin cross-linking and/or transglutaminases
02/15/2000US6025188 Degrading a mycotoxin having a tricabyllic ester by contacting with an esterase enzyme; for treating grain, silage, food crops and animal feed
02/15/2000US6025185 Fungus wherein the areA gene has been modified and an areA gene from Aspergillus oryzae
02/15/2000US6025184 Cosmid contained in atcc 69789 comprising a dna fragment isolated from klebsiella pneumoniae which encodes an active glycerol dehydratase; for efficient production
02/15/2000US6025183 Recombinant expression vector of a dna sequence encoding human acetylcholinesterase and a human promoter; for screening assays to test treatments for alzheimer's disease, retinal photoreceptor degeneration, hematopoietic disorders
02/15/2000US6025181 Equine herpesvirus-4TK mutant
02/15/2000US6025180 Asp1
02/15/2000US6025179 Method for cloning and producing the SnaBI restriction endonuclease and purification of the recombinant SnaBI restriction endonuclease
02/15/2000US6025178 Human phospholipase A2 and related nucleic acid compounds
02/15/2000US6025176 For diagnosis and monitoring of insulin dependent diabetes mellitis; antidiabetic agents
02/15/2000US6025175 Amino acid sequence; for screening new bactericides and bacteristats to treat otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, pleural empyema and endocarditis; diagnosis of infections
02/15/2000US6025174 Amino acid sequence; for production of new antibiotics by derivatizing vancomycin glycopeptides
02/15/2000US6025173 Amino acid sequence; for producing new antibiotics by derivatizing presently available ones such as vancomycin and teichoplanin glycopeptides
02/15/2000US6025172 Amino acid sequence of the delta-12-desaturase enzyme; for reducing autooxidation by changing fatty acid composition in the kernel oil of hazelnuts for reduced spoilage
02/15/2000US6025167 RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
02/15/2000US6025159 Nucleotide sequence from trigonopsis variabilis; for increased expression of heterologous genes in host systems by replacing promoter of selectable marker, leading to amplification of the plasmid
02/15/2000US6025156 Amino acid sequence; for discovery of antibiotics, bactericides, bacteristats against staphylococcus infections
02/15/2000US6025145 Sensitive, reliable immunoassay using eukaryotic cells expressing receptor construct comprising flag polypeptide and tyrosine kinase receptor, exposing to ligand, lysing cells and measuring phosphotyrosine
02/15/2000US6025143 Purified monoclonal or polyclonal antibody against a peptide having specific amino acid sequence from a gene controlled by andogens and isolated from submaxillary gland of the rat; for diagnosis, detection and therapeutics
02/15/2000US6025123 Human succinyl-coenzyme a synthetase holoenzyme
02/15/2000US6024936 Antibody-based method of localizing activated thrombin receptors
02/15/2000US6024688 Angiostatin fragments and method of use
02/15/2000CA2180154C Gene for fatty acid desaturase, vector containing said gene, plant transformed with said gene, and process for creating said plant
02/15/2000CA2173106C Bleaching compositions comprising protease enzymes
02/15/2000CA2085292C Enzyme of use in chitosan hydrolysis
02/15/2000CA2077461C Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway
02/15/2000CA2058398C 1,4 benzothiazine-2-acetic acid derivatives, processes for production thereof
02/15/2000CA2015994C Human lactoferrin cdna sequence
02/15/2000CA2005300C Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
02/15/2000CA1340900C Method for indentifying and using biosynthetic or regulatory genes for enhanced production of secondary metabolites
02/10/2000WO2000006763A1 Fusion products containing insoluble proteinaceous tag
02/10/2000WO2000006759A2 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same
02/10/2000WO2000006756A1 Sulfur metabolism enzymes
02/10/2000WO2000006755A2 Modification of starch biosynthetic enzyme gene expression to produce starches in grain crops
02/10/2000WO2000006752A1 Bending and/or leaning-induced plant promoter
02/10/2000WO2000006750A2 Method for autoactivation of procaspase 8
02/10/2000WO2000006749A2 Sulfur metabolism enzymes
02/10/2000WO2000006748A2 Crystallizable farnesyl protein transferase compositions, crystals thereby obtained and methods for use
02/10/2000WO2000006747A2 Enzymes for biopolymer production
02/10/2000WO2000006746A1 Methods and means for inducing tolerance to stress
02/10/2000WO2000006728A2 Phosphorylation effectors
02/10/2000WO2000006723A1 Tumor associated antigen peptides and use of same as anti-tumor vaccines
02/10/2000WO2000006718A2 Expression of functional eukaryotic proteins
02/10/2000WO2000006712A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof
02/10/2000WO2000006709A1 Human protein kinase h2lau20
02/10/2000WO2000006708A1 Novel polypeptide
02/10/2000WO2000006707A1 Screening process for identifying catalytic activity using chromogenic and fluorogenic compounds
02/10/2000WO2000006706A2 Map kinase phosphatase mutant
02/10/2000WO2000006587A1 New cofactors for methyltransferases
02/10/2000WO2000006179A1 Cryogranulation of activated protein c
02/10/2000WO1999067356A3 Propionibacterium vector
02/10/2000WO1999065936A3 Composition for the treatement of immune deficiencies and methods for its preparation and use
02/10/2000WO1999064613B1 D-ribulose-5-phosphate-3-epimerase nematode response gene
02/10/2000WO1999061600A3 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
02/10/2000WO1999054479A9 INHIBITION OF ALKYL HYDROPEROXIDE REDUCTASE, SUBUNIT C (AhpC) TO IMPART SUSCEPTIBILITY TO ANTIMICROBIAL REACTIVE NITROGEN INTERMEDIATES
02/10/2000WO1999053073A3 Interconversion of plant fatty acid desaturases and hydroxylases
02/10/2000WO1999053038A3 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
02/10/2000WO1999045126A3 Enhanced prodrug activation
02/10/2000WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins
02/10/2000DE19840771A1 A thermostable in vitro polymerase complex for template-dependent elongation of nucleic acids in amplification or reverse transcription methods
02/10/2000DE19822823A1 Neue Peptidfragmente zur Reinigung von Proteinen New peptide fragments in protein purification
02/10/2000CA2338981A1 .alpha.1,3-fucosyltransferase nucleic acid and polypeptide
02/10/2000CA2338766A1 Cryogranulation of activated protein c
02/10/2000CA2338643A1 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof
02/10/2000CA2337666A1 Map kinase phosphatase mutant
02/10/2000CA2337496A1 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same
02/10/2000CA2336706A1 Bending and/or leaning-induced plant promoter
02/10/2000CA2335644A1 Phosphorylation effectors
02/10/2000CA2331777A1 Expression of functional eukaryotic proteins
02/09/2000EP0978563A1 Delta 9-desaturase gene